UPNT Research Institute, LLC

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• CG Oncology, Inc.1 trial
• UroGen Pharma Ltd.1 trial

Running trials

• Recruiting

  A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  NCT06774131· Phase 3· UroGen Pharma Ltd.· Source

  Contact: Grace Yoon

• Recruiting

  Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  NCT06567743· Phase 2· CG Oncology, Inc.· Source

  Contact: Michael Collini, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting